Related Experiment Videos
X-ray crystallographic structure of a papain-leupeptin complex
E Schröder1, C Phillips, E Garman
1University of Oxford, Laboratory of Molecular Biophysics, UK.
FEBS Letters
|January 2, 1993
Summary
The papain-leupeptin complex structure reveals leupeptin binding to papain's active site. This interaction involves a covalent bond and hydrogen bonds, elucidating enzyme-inhibitor mechanisms.
Area of Science:
- Structural Biology
- Biochemistry
- Enzymology
Background:
- Papain is a cysteine protease with a well-characterized active site.
- Leupeptin is a known inhibitor of serine and cysteine proteases.
- Understanding enzyme-inhibitor interactions is crucial for drug design.
Purpose of the Study:
- To determine the three-dimensional structure of the papain-leupeptin complex.
- To elucidate the binding mode of leupeptin within the papain active site.
- To provide insights into the mechanism of papain inhibition by leupeptin.
Main Methods:
- X-ray crystallography was employed to determine the complex's structure.
- Data were collected to a resolution of 2.1 Angstroms.
- The R-factor was determined to be 19.8%.
Main Results:
- Leupeptin was observed to interact with the S subsites of the papain active site, not the S' subsites.
- A covalent bond was formed between the inhibitor's carbonyl carbon and the Cys-25 sulfur atom of papain.
- The inhibitor's carbonyl oxygen formed hydrogen bonds with Gln-19 and Cys-25, interacting with the oxyanion hole.
Conclusions:
- The determined structure provides a detailed atomic-level understanding of papain-leupeptin interaction.
- Leupeptin acts as a mechanism-based inhibitor by forming a covalent adduct with papain's active site.
- The findings highlight the importance of the oxyanion hole and specific active site residues in inhibitor binding.